Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Diabetes Care 30:e83 2007
DOI: 10.2337/dc07-0622
© 2007 by the American Diabetes Association
This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bastard, J.-P.
Right arrow Articles by Rabasa-Lhoret, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bastard, J.-P.
Right arrow Articles by Rabasa-Lhoret, R.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Online Letters: Comments and Responses
Online Letters

Muscle and Liver Insulin Resistance Indexes Derived From the Oral Glucose Tolerance Test

Response to Abdul-Ghani et al.

Jean-Philippe Bastard, MD, PHD1,2,3, May Faraj, PHD4, Antony D. Karelis, PHD4, Jennifer Lavasseur, BSC4, Dominique Garrel, MD4, Denis Prud'homme, PHD5 and Rémi Rabasa-Lhoret, MD, PHD4,6

1 AP-HP, Hôpital Hôpital Tenon, Service de Biochimie et Hormonologie, Paris, France
2 INSERM, U680, Paris, France
3 Faculté de Médecine, Université Pierre et Marie Curie-Paris 6, UMRS680, Paris, France
4 Laboratoire des Dysfonctions Métaboliques, Department of Nutrition, Université de Montréal, Montreal, Quebec, Canada
5 School of Human Kinetics, Faculty of Health Sciences, University of Ottawa, Ottawa, Ontario, Canada
6 Centre de Recherche du Centre Hospitalier de L'Université de Montréal, Montréal Québec

Address correspondence to Rémi Rabasa-Lhoret, MD, PhD, Département of Nutrition, Université de Montréal, Montréal, Québec, Canada. E-mail: remi.rabasa-lhoret{at}umontreal.ca

It was recently reported (1) that it is important to assess both hepatic and muscle insulin resistance because doing so can lead to different treatment approaches according to the insulin resistance status of each organ. Currently, the hyperinsulinemic-euglycemic clamp is the gold standard for the measurement of liver and muscle insulin sensitivity (2). However, this method is unpractical in clinical practice. For this reason, Abdul-Ghani et al. (1) developed several formulas that were derived from an oral glucose tolerance test (OGTT) for the assessment of both liver and muscle insulin sensitivity in human subjects. These formulas had higher correlation coefficients with clamp data than other classically published indexes derived from either fasting or OGTT measurements (1). However, they were tested in a heterogeneous population with a wide range of BMI measurements (19.9–64.2 kg/m2), which included both male (1/3) and female (2/3) subjects in whom one-third were glucose intolerant (1).

We tested the muscle insulin resistance index in a more homogeneous population of 113 nondiabetic postmenopausal overweight and obese women (aged 57.7 ± 0.5 years, BMI 32.4 ± 0.4 kg/m2) who were recruited from the Department of Nutrition at the University of Montreal for a weight-loss study (3). This population is at high risk for insulin resistance. The studied patients displayed an OGTT with glucose and insulin measurements and a hyperinsulinemic-euglycemic clamp with an insulin infusion rate of 75 mU/m2 per min for 180 min, which allowed an estimation of muscle insulin resistance. Correlations were calculated using the Spearman's rank test. We found a significant correlation (rho = 0.542, P < 0.0001) between OGTT-derived index from Abdul-Ghani et al. (1) and hyperinsulinemic-euglycemic clamp results expressed as M (milligrams per minute per killograms) divided by I (steady-state insulin concentration). However, this correlation was not higher than those observed with the Stumvoll index (rho = 0.442, P < 0.0001), Matsuda index (rho = 0.627, P < 0.0001), or a new recently proposed simple index for assessing insulin sensitivity derived from an OGTT (rho = 0.680, P < 0.0001), which is calculated as 1/[Log (sum glucose t0 + 30 + 90 + 120 mmol/l) + Log (sum insulin t0 + 30 + 90 + 120 µUI/ml)] (3).

Therefore, although it is probably useful to screen for both liver and muscle insulin sensitivity, it is also important to define the most reliable and simple tool to evaluate insulin sensitivity according to the population investigated. Indeed, such an index might be different according to age, sex, and weight and glycemic status, particularly for muscle insulin sensitivity evaluation.

References

  1. Abdul-Ghani MA, Matsuda M, Balas B, DeFronzo RA: Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test. Diabetes Care 30:89–94, 2007[Abstract/Free Full Text]
  2. DeFronzo RA, Tobin JD, Andreas R: Glucose clamp technique: a method for quantifying insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. Am J Physiol 85:2402–2410, 1979
  3. Bastard JP, Vandernotte JM, Faraj M, Karelis AD, Messier L, Malita FM, Garrel D, Prud'homme D, Rabasa-Lhoret R: Relationship between the hyperinsulinemic-euglycemic clamp and a new simple index assessing insulin sensitivity in overweight and obese postmenopausal women. Diabetes Metab 2007 May 10; [Epub ahead of print]

Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Diabetes CareHome page
M. A Abdul-Ghani, M. Matsuda, B. Balas, and R. A. DeFronzo
Muscle and Liver Insulin Resistance Indexes Derived From the Oral Glucose Tolerance Test: Response to Bastard et al.
Diabetes Care, July 1, 2007; 30(7): e84 - e84.
[Full Text] [PDF]


This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bastard, J.-P.
Right arrow Articles by Rabasa-Lhoret, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bastard, J.-P.
Right arrow Articles by Rabasa-Lhoret, R.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum